3Q4-20776-60733

3 vaccinations 6 coded responses 32 check-ins 6 free-text entries 4 call cases

Sex: Female
Age at first dose: 31-35
ZIP prefix: 802 / CO
Registered: 2020-12-23

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-23
Registered in v-safe
2020-12-23
Dose 1 — Pfizer-BioNTech
2020-12-23
Survey response — day 0, dose 1
MedDRA: Dizziness — Feeling: Good · Fever · Headache

Free text: Dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2020-12-24
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2020-12-25
Survey response — days 1–6 daily, dose 1
MedDRA: Dizziness — Feeling: Good

Free text: Dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2020-12-26
Survey response — days 1–6 daily, dose 1
MedDRA: Dizziness — Feeling: Good · Headache

Free text: Dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2020-12-27
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-28
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-29
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-30
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-01-06
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-13
Health check-in — day 21, dose 1
Feeling: Good

Adult check-in
2021-01-14
Dose 2 — Pfizer-BioNTech
2021-01-15
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work

Adult check-in
2021-01-15
Report sent to call center — days 1–6 daily, dose 2
Be unable to work

1 call case(s)
2021-01-16
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-01-17
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Itching · Fatigue or tiredness

Adult check-in
2021-01-18
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-19
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-20
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-21
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-01-28
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-04
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-11
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-02-18
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-02-25
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-15
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-07-15
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-09-11
Dose 3 — Pfizer-BioNTech
2021-09-28
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2021-10-02
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2021-10-09
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2021-10-18
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2021-10-23
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2021-12-11
Survey response — 3 months, dose 3
MedDRA: Gastroenteritis viral — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Had a stomach virus

MedDRA releases: 2024-11 · check-in free text available
2021-12-11
Report sent to call center — 3 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2021-12-14
Call 2 — Left Voicemail
2022-03-12
Survey response — 6 months, dose 3
MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Covid 19- had for 7 days

MedDRA releases: 2024-11 · check-in free text available
2022-03-12
Report sent to call center — 6 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-03-15
Call 1 — Left Voicemail
2022-09-11
Survey response — 12 months, dose 3
MedDRA: Nasopharyngitis, Pregnancy, Sinusitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Pregnancy - started 5/16/22 Had a cold/ sinus infection- End of Aug 2022

MedDRA releases: 2024-11 · check-in free text available
2022-09-11
Report sent to call center — 12 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-09-13
Call 1 — Left Voicemail
2022-09-13
Call 2 — Left Voicemail
2022-09-13
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-23	Pfizer-BioNTech
2	2021-01-14	Pfizer-BioNTech
3	2021-09-11	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2021-01-15	priority 2/3
2021-12-11	Unsuccessful
2022-03-12	Unsuccessful
2022-09-11	Unsuccessful

Free text

Release 1 — day 0, dose 1

2020-12-23

Systemic reaction (other): Dizziness

Release 1 — days 1–6 daily, dose 1

2020-12-25

Systemic reaction (other): Dizziness

2020-12-26

Systemic reaction (other): Dizziness

Release 10 — 3 months, dose 3

2021-12-11

Symptoms: Had a stomach virus

Release 11 — 6 months, dose 3

2022-03-12

Symptoms: Covid 19- had for 7 days

Release 12 — 12 months, dose 3

2022-09-11

Symptoms: Pregnancy - started 5/16/22 Had a cold/ sinus infection- End of Aug 2022

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	COVID-19	·	·	✓
SD	Gastroenteritis viral	·	·	✓
SD	Nasopharyngitis	·	·	✓
SD	Pregnancy	·	·	✓
SD	Sinusitis	·	·	✓
SRO	Dizziness	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release